ACCOUNTS RECEIVABLE

12 Months Ended

Dec. 31, 2011

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE

9.     ACCOUNTS RECEIVABLE

• The components of accounts receivable as of December 31, 2011 and 2010 were as follows:

	2011			2010
Trade	$	480,867		$	240,712
Less allowance for doubtful accounts		(12,328	)		(6,692	)
		468,539			234,020
Royalties		21,774			16,424
Other		78,955			24,375
	$	569,268		$	274,819

• The increase in accounts receivable primarily reflects the addition of PharmaSwiss', Sanitas', Dermik's, Ortho Dermatologics', iNova's and Afexa's revenues from products and services in 2011, as well as revenue growth of the existing business, and the receivable from ValueAct Capital Master Fund, L.P. ("ValueAct") related to withholding taxes on the March 2011 share repurchase.